Improving Door-to-Antibiotic Administration Time in Patients With Fever and Suspected Chemotherapy-Induced Neutropenia: A Tertiary Care Center Experience
Background: Chemotherapy-induced febrile neutropenia (FN) is a major cause of morbidity and mortality in cancer patients if not treated promptly. As we were facing considerable delays in the management of chemotherapy-induced febrile neutropenic patients in the Emergency Department (ED), we initiate...
Main Authors: | Reem Al Sudairy, Mohsen Alzahrani, Mohammad Alkaiyat, Mona Alshami, Abdullah Yaqub, Maha Al Fayadh, Khaled Al-Surimi, Abdul Rahman Jazieh |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2019-08-01
|
Series: | Global Journal on Quality and Safety in Healthcare |
Subjects: | |
Online Access: | https://jqsh.org/doi/pdf/10.4103/JQSH.JQSH_1_19 |
Similar Items
-
Prevention of febrile neutropenia in oncological patients: real-world data
by: Kirill V. Sapozhnikov, et al.
Published: (2023-05-01) -
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by: Sang Ngoc Nguyen, et al.
Published: (2022-08-01) -
Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
by: Razan Zatarah, et al.
Published: (2022-10-01) -
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
by: Maria Bachlitzanaki, et al.
Published: (2023-10-01) -
Febrile Neutropenia Due To Brucellosis: Case Report
by: Abdullah Sakin, et al.
Published: (2012-06-01)